RT Journal Article
SR Electronic
T1 The OMERACT Ultrasound Working Group 10 Years On: Update at OMERACT 12
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP jrheum.141462
DO 10.3899/jrheum.141462
A1 George A.  Bruyn
A1 Esperanza Naredo
A1 Annamaria Iagnocco
A1 Peter V.  Balint
A1 Marina Backhaus
A1 Frederique Gandjbakhch
A1 Marwin Gutierrez
A1 Andrew Filer
A1 Stephanie Finzel
A1 Kei Ikeda
A1 Gurjit S.  Kaeley
A1 Silvia Magni Manzoni
A1 Sarah Ohrndorf
A1 Carlos Pineda
A1 Bethan Richards
A1 Johannes Roth
A1 Wolfgang A.  Schmidt
A1 Lene Terslev
A1 Maria Antonietta  D’Agostino
YR 2015
UL http://www.jrheum.org/content/early/2015/03/10/jrheum.141462.abstract
AB Musculoskeletal ultrasound (US) now thrives as an established imaging modality for the investigation and management of chronic inflammatory arthritis. We summarize here results of the Outcome Measures in Rheumatology (OMERACT) US working group (WG) projects of the last 2 years. These results were reported at the OMERACT 12 meeting at the plenary session and discussed during breakout sessions. Topics included standardization of US use in rheumatic disease over the last decade and its contribution to understanding musculoskeletal diseases. This is the first update report of WG activities in validating US as an outcome measure in musculoskeletal inflammatory and degenerative diseases, including pediatric arthritis, since the OMERACT 11 meeting.